IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MUNARI, Enrico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.739
EU - Europa 456
AS - Asia 424
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
OC - Oceania 1
Totale 2.623
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.735
HK - Hong Kong 175
SG - Singapore 144
UA - Ucraina 120
IE - Irlanda 84
FI - Finlandia 79
TR - Turchia 78
DE - Germania 72
GB - Regno Unito 38
IT - Italia 25
CN - Cina 23
BE - Belgio 15
CZ - Repubblica Ceca 5
RU - Federazione Russa 5
CA - Canada 4
SE - Svezia 4
NL - Olanda 3
AP - ???statistics.table.value.countryCode.AP??? 2
CH - Svizzera 2
FR - Francia 2
PK - Pakistan 2
AU - Australia 1
GR - Grecia 1
IN - India 1
JP - Giappone 1
MU - Mauritius 1
RS - Serbia 1
Totale 2.623
Salva come PNG Salva come JPEG
Città #
Fairfield 320
Hong Kong 175
Woodbridge 157
Princeton 140
Seattle 134
Ashburn 128
Wilmington 124
Singapore 114
Houston 108
Cambridge 103
Jacksonville 100
Helsinki 79
Dublin 78
Istanbul 77
New York 68
Ann Arbor 57
San Diego 30
Des Moines 28
Shanghai 20
Chandler 18
Menlo Park 16
Brussels 15
London 13
Romola 9
Brno 5
Chiswick 5
Los Angeles 5
Norwalk 5
Wandsworth 5
Beijing 3
Kilburn 3
Milan 3
St Petersburg 3
Vancouver 3
Würzburg 3
Acton 2
Ebikon 2
Hounslow 2
Karachi 2
New Bedfont 2
Nijmegen 2
Paris 2
Rome 2
Tolentino 2
Bari 1
Belgrade 1
Brescia 1
Chicago 1
Falkenstein 1
Genoa 1
Kocaeli 1
Moscow 1
Negrar 1
North Bergen 1
Perm 1
Piraeus 1
Prescot 1
Pune 1
Queens 1
Ronkonkoma 1
Southwark 1
Sydney 1
Torino 1
Toronto 1
Verona 1
Villa di Briano 1
Totale 2.194
Salva come PNG Salva come JPEG
Nome #
Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors 89
Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma 83
MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge 63
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 60
⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer 58
Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma 57
Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions 55
Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: a tissue microarray study of 112 cases 54
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 53
PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263 53
Correction: Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma 50
Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: a tissue microarray study of 112 cases 48
Cyclin A1 expression predicts progression in pT1 urothelial carcinoma of bladder: a tissue microarray study of 149 patients treated by transurethral resection 48
MicroRNA expression profiling of Xp11 renal cell carcinoma 48
NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines 46
Prevalence of PD-L1 expression in head and neck squamous precancerous lesions: a systematic review and meta-analysis 45
The epidermal growth factor receptor is frequently overexpressed in penile squamous cell carcinomas: a tissue microarray and digital image analysis study of 112 cases 44
Multiplex fluorescence in situ hybridisation to detect anaplastic lymphoma kinase and ROS proto-oncogene 1 receptor tyrosine kinase rearrangements in lung cancer cytological samples 44
Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma 43
ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder 42
An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine 42
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 41
Validation of 34betaE12 immunoexpression in clear cell papillary renal cell carcinoma as a sensitive biomarker 40
Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma 40
Insulin-like growth factor-1 receptor expression in upper tract urothelial carcinoma 40
Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma 38
Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms 37
ALK-positive anaplastic large cell lymphoma with PAX-5 expression: report of a case 37
Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder: a retrospective study of patients treated using radical cystectomy 37
TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine 36
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 36
High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins 35
Human papillomavirus infection and immunohistochemical p16(INK4a) expression as predictors of outcome in penile squamous cell carcinomas 33
PD-L1 expression heterogeneity in non-small cell lung cancer: defining criteria for harmonization between biopsies and whole sections 33
Proximal CD13 Versus Distal GATA-3 Expression in Renal Neoplasia According to WHO 2016 Classification 33
PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability 33
Non-small cell lung cancer: land of conquest for immunotherapy 32
Group 3 innate lymphoid cells regulate neutrophil migration and function in human decidua 32
PD-L1 expression in non-small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory developed test using clone E1L3N in comparison with 22C3 and SP263 assays 32
Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary Malignancies 32
Overexpression of Insulin-like Growth Factor-1 Receptor Is Associated With Penile Cancer Progression 30
Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes 29
Strong association of insulin-like growth factor 1 receptor expression with histologic grade, subtype, and HPV status in penile squamous cell carcinomas: a tissue microarray study of 112 cases 29
Human Innate Lymphoid Cells: Their Functional and Cellular Interactions in Decidua 28
Expression of programmed cell death ligand 1 in non-small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 Assay 28
Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome 28
Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma 27
PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non-Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs: An Interclone Evaluation by Differently Trained Pathologists 27
Predicting progression in T1 non-muscle-invasive bladder cancer: back to histology 27
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma 26
Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes? 26
Evaluation of S-phase fraction as a prognostic marker in mantle cell lymphoma 25
Assessment of HER2 protein overexpression and gene amplification in renal collecting duct carcinoma: Therapeutic implication 25
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 25
TCL1A expression in marginal zone lymphoma: a clinico-pathological evaluation in paired spleen and bone marrow samples 22
Cathepsin k: A novel diagnostic and predictive biomarker for renal tumors 22
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation 21
Wilms’ tumor primary cells display potent immunoregulatory properties on nk cells and macrophages 20
PD-1/pd-l1 in cancer: Pathophysiological, diagnostic and therapeutic aspects 20
Challenges facing pathologists evaluating PD-L1 in head & neck squamous cell carcinoma 20
Artificial intelligence applications for pre-implantation kidney biopsy pathology practice: a systematic review 19
Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection 19
Characterization of human NK cell-derived exosomes: Role of DNAM1 receptor in exosome-mediated cytotoxicity against tumor 19
Pediatric tumors-mediated inhibitory effect on nk cells: The case of neuroblastoma and Wilms’ tumors 19
Concurrent targeting of potential cancer stem cells regulating pathways sensitizes lung adenocarcinoma to standard chemotherapy 18
PD-L1 evaluation in head and neck squamous cell carcinoma: Insights regarding specimens, heterogeneity and therapy 17
TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study 16
Exploiting Human NK Cells in Tumor Therapy 16
Artificial intelligence-based tools applied to pathological diagnosis of microbiological diseases 16
Impact of PD-L1 and PD-1 Expression on the Prognostic Significance of CD8+ Tumor-Infiltrating Lymphocytes in Non-Small Cell Lung Cancer 15
Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: Functional analysis and expression of PD-1 receptor 15
PMN-MDSC are a new target to rescue graft-versus-leukemia activity of NK cells in haplo-HSC transplantation 15
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells 14
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 14
Artificial intelligence in head and neck cancer diagnosis 14
Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems 14
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 14
Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28 14
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression 14
“Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy 13
The immune checkpoint PD-1 in natural killer cells: Expression, function and targeting in tumour immunotherapy 12
Helper Innate Lymphoid Cells in Human Tumors: A Double-Edged Sword? 12
Different effects of NK cells and NK-derived soluble factors on cell lines derived from primary or metastatic pancreatic cancers 11
Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis 11
Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity 11
PD-L1 Expression in de Novo Metastatic Castration-sensitive Prostate Cancer 11
Program death ligand-1 immunocytochemistry in lung cancer cytological samples: A systematic review 10
Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma 7
Technical and Diagnostic Issues in Whole Slide Imaging Published Validation Studies 7
NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines 5
Totale 2.719
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.599
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.599
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.259 0 0 435 104 150 56 20 123 66 159 50 96
2021/2022398 9 44 11 41 4 7 9 56 84 29 34 70
2022/2023263 81 0 6 2 5 89 6 17 32 2 13 10
2023/2024539 17 14 12 96 14 70 11 27 181 2 4 91
2024/2025260 4 9 11 118 118 0 0 0 0 0 0 0
Totale 2.719